West Pharmaceutical Services Inc Receivables Turnover Ratio (WST), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


West Pharmaceutical Services Inc   (NYSE: WST)
 

West Pharmaceutical Services Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


West Pharmaceutical Services Inc 's ability to collect accounts receivable sequentially worsen to 5.12, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. West Pharmaceutical Services Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 71 days, from 70 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 163 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 171 to 1356.

What is Receivable Turnover Ratio?
What is West Pharmaceutical Services Inc Selling?


What is Receivable Turnover Ratio?





WST Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 22.25 % 26.12 % 3.96 % 19.21 % 21.49 %
Y / Y Revenue Change 13.89 % 20.99 % 7.65 % 7.71 % 9.1 %
Receivable Turnover Ratio (TTM) 5.12 5.22 5.29 5.24 5.37
WST's Total Ranking # 1356 # 171 # 1211 # 1247 # 1188
Accounts Receivable average collection period days 71 70 69 70 68
Seq. Receivable Change 3.85 % 19.36 % -8.1 % 7.31 % 7.14 %
Seq. Revenue Change 3.3 % 4.78 % 0.2 % 5.01 % 9.74 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 164
Overall Market # 1356

Receivable Turnover Ratio Statistics
High Average Low
0.93 0.85 0.77
(Dec 31 2021)   (Dec 31 2025)






Financial Statements
West Pharmaceutical Services Inc 's Accounts Receivable $ 712 Millions Visit WST's Balance sheet
West Pharmaceutical Services Inc 's Sales TTM $ 3,327 Millions Visit WST's Income Statement
Sources of WST's Revenues Visit WST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
WST's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
WST's Growth Rates WST's Roa WST's Inventory Turnover Ratio WST's Dividend Comparisons
WST's Profitability Ratios WST's Roi WST's Asset Turnover Ratio WST's Dividend Growth
WST's Valuation Ratios WST's Roe WST's Financial Strength Ratios WST's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Nrc Health  12.72 $ 139.996  Millions$ 11.004  Millions
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Radnet Inc   10.53 $ 2,268.932  Millions$ 215.450  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Irhythm Holdings Inc   10.42 $ 825.702  Millions$ 79.250  Millions
Integrated Biopharma Inc  10.38 $ 42.568  Millions$ 4.101  Millions
Viemed Healthcare Inc   10.36 $ 301.606  Millions$ 29.102  Millions
Lensar Inc   10.33 $ 60.264  Millions$ 5.836  Millions
Immucell Corporation  10.30 $ 29.777  Millions$ 2.891  Millions
Addus Homecare Corp  10.25 $ 1,475.610  Millions$ 143.923  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.